Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanzhou A-type botulinum toxin for overactive bladder
CTR20131190Phase 3Active
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in overactive bladder (OAB), neurogenic bladder, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Started Mar 2016; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)neurogenic bladder
Beyond the preview
Go deeper on CTR20131190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131190.